Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-11 @ 4:01 PM
Study NCT ID:
NCT01652794
Status:
COMPLETED
Last Update Posted:
2015-08-04
First Post:
2012-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leydig Cell Tumor | View |
| None | Ovarian Sarcoma | View |
| None | Ovarian Stromal Cancer | View |
| None | Pseudomyxoma Peritonei | View |
| None | Recurrent Cervical Cancer | View |
| None | Recurrent Endometrial Carcinoma | View |
| None | Recurrent Fallopian Tube Cancer | View |
| None | Recurrent Ovarian Epithelial Cancer | View |
| None | Recurrent Ovarian Germ Cell Tumor | View |
| None | Recurrent Primary Peritoneal Cavity Cancer | View |
| None | Recurrent Uterine Sarcoma | View |
| None | Recurrent Vaginal Cancer | View |
| None | Recurrent Vulvar Cancer | View |
Keywords: